Education
About Us
Working with TipRanks
Follow Us
Gelion PLC (GB:GELN)
LSE:GELN
GELN Stock Chart & Stats
18.50p
1.00p(6.25%)
At close: 4:00 PM EST
18.50p
1.00p(6.25%)
Day’s Range― - ―
52-Week Range9.00p - 30.00p
Previous CloseN/A
Volume5.00K
Average Volume (3M)395.75K
Market Cap
£43.59M
Enterprise Value31.07M
Total Cash (Recent Filing)£10.52M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta-0.33
Next Earnings
Nov 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding229,421,460
10 Day Avg. Volume121,404
30 Day Avg. Volume395,753
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)3.53
Price to Sales (P/S)38.63
P/FCF Ratio-7.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strategic Partnerships & IPHigh-quality scientific partners and ongoing patent activity provide durable technical validation, access to external expertise, and credibility for commercialization. These relationships and IP reduce R&D execution risk, help transfer prototyping to scale, and support long-term market entry pathways and licensing options.
Scale-up Of Cathode Materials (CAM)Demonstrated step-change scale-up in CAM density signals progress from lab to commercial-relevant manufacturing. Achieving commercial aerial capacity is a structural milestone that improves energy density economics, supports product-spec compliance, and materially de-risks unit-cost and supply capability required for longer-duration stationary storage sales.
Conservative Leverage On Balance SheetExtremely low leverage preserves solvency and strategic optionality while the company scales. With limited debt obligations, management can prioritize nondilutive grants and targeted CapEx, reducing bankruptcy risk and allowing more flexible timing for commercialization investments as technology and partnerships mature.
Bears Say
Persistent Negative Cash FlowSustained negative operating and free cash flow creates an ongoing funding requirement and increases reliance on external capital and grants. Over the medium term this constrains reinvestment, raises dilution or refinancing risk, and limits the firm's ability to scale production and commercial deployments without securing additional non-dilutive or equity funding.
Delayed Integration RevenueA long sales cycle and deferred revenue from the Integration business delay meaningful commercial cash flows and make short-term recovery dependent on grants and partnerships. This elongates the path to sustainable margins and places pressure on execution consistency and partner-driven deployment schedules.
Unproven Full-cell Life & Yield IssuesIncomplete calendar-life validation and outstanding process-engineering to lift yields are structural product risks. Without proven long-duration cycle life and scalable yields, commercial customers may delay adoption, margins remain uncertain, and significant engineering investment will be needed before reliable product economics and large-scale deployments are possible.
Gelion PLC News
GELN FAQ
What was Gelion PLC’s price range in the past 12 months?
Gelion PLC lowest share price was 9.00p and its highest was 30.00p in the past 12 months.
What is Gelion PLC’s market cap?
Gelion PLC’s market cap is £43.59M.
When is Gelion PLC’s upcoming earnings report date?
Gelion PLC’s upcoming earnings report date is Nov 11, 2026 which is in 252 days.
How were Gelion PLC’s earnings last quarter?
Gelion PLC released its earnings results on Mar 02, 2026. The company reported -0.017p earnings per share for the quarter, missing the consensus estimate of N/A by -0.017p.
Is Gelion PLC overvalued?
According to Wall Street analysts Gelion PLC’s price is currently Overvalued.
Does Gelion PLC pay dividends?
Gelion PLC does not currently pay dividends.
What is Gelion PLC’s EPS estimate?
Gelion PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Gelion PLC have?
Gelion PLC has 229,421,460 shares outstanding.
What happened to Gelion PLC’s price movement after its last earnings report?
Gelion PLC reported an EPS of -0.017p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 8.333%.
Which hedge fund is a major shareholder of Gelion PLC?
Currently, no hedge funds are holding shares in GB:GELN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Gelion PLC Stock Smart Score
Company Description
Gelion PLC
Gelion plc engages in the research and development, design, manufacture, and sale of battery systems in the United Kingdom and internationally. The company offers zinc-bromide batteries under the Endure name. Its products are used in various applications, which include industrial light towers, solar and wind farms, desalination plants, mining pumps, passenger and heavy vehicles, electric buses and trains, and irrigation systems and other agricultural applications, as well as used by commercial and industrial enterprises and grid operators. The company was incorporated in 2015 and is headquartered in Eveleigh, Australia.
Technical Analysis
Options Prices
Currently, No data available
---